BioSpace News Archive

Interventional radiologists participating in a collaborative house call model in rural Indiana helped reduce emergency department use by 77 percent and hospital readmissions by 50 percent for nearly 1,000 elderly homebound patients with chronic illnesses, according to research presented during a virtual session of the Society of Interventional Radiology’s 2020 Annual Scientific Meeting on June 15.

While medication non-adherence in clinical trials has been widely recognized as a challenge in drug development1, reported non-adherence rates have been largely anecdotal, isolated to individual studies, and varied widely in their estimations

ACADIA Pharmaceuticals Submits Supplemental New Drug Application to U.S. FDA for NUPLAZID ® (pimavanserin) for the Treatment of Hallucinations and Delusions Associated with Dementia-Related Psychosis - Submission based on positive results from the Phase 3 HARMONY study which showed a statistically significant 2.8 fold reduction in the risk of relapse of psychosis SAN DIEGO--( BUSINESS WIRE )-- ACADIA Pharmaceuticals Inc. (Nasdaq: ACAD) announced toda

Sedative that Received FDA Emergency Use Authorization Now Available from Fresenius Kabi for use in Mechanically Ventilated COVID-19 patients FDA authorization allows importation of Propoven 2% (propofol 20 mg per mL), double the concentration of the widely used drug Diprivan ® COVID-19 patients requiring mechanical ventilation increased demand for propofol worldwide LAKE ZURICH, Ill.--( BUSINESS WIRE )-- Fresenius Kabi announced today t

Bayer to Present Results from Head-to-Head PK Comparison Study of Jivi ® Versus Adynovate ® in Late-Breaker Presentation at the Annual World Federation of Hemophilia Virtual Summit WHIPPANY, N.J.--( BUSINESS WIRE )-- Bayer announced today it will present new data highlighting the results from the first head-to-head study directly comparing the pharmacokinetic (PK) profiles of two extended half-life (EHL) recombinant factor VIII (FVIII) therapies, Jivi ® (

Through the ADA’s first ever endorsement of a dental benefits technology company - Bento, a modern alternative to traditional dental insurance, looks to provide access to affordable oral care nationwide.

Redox, Inc., the leading interoperability platform for healthcare data exchange, is working with FDA-authorized COVID-19 testing company Curative to safely connect patient data to state public health departments for notification of results

Lawley Pharmaceuticals and Tanner Pharma Group announced today that they have initiated a global named patient program for AndroFeme ® 1 testosterone cream for women. AndroFeme ® 1 is licensed by Western Australian regulatory authorities and is indicated for the treatment of postmenopausal women with hypoactive sexual desire dysfunction (HSDD). Lawley has appointed Tanner Pharma Group as

Rafarma Pharmaceuticals, Inc. is happy to announce commencement of tests for its new product “HempySleep”.

Applied BioMath (www.appliedbiomath.com), the industry-leader in applying systems pharmacology and mechanistic modeling, simulation, and analysis to de-risk drug research and development, today announced they have entered a two-year strategic partnership with Xencor, Inc.